337
Participants
Start Date
July 30, 2019
Primary Completion Date
November 10, 2023
Study Completion Date
January 31, 2024
Tezepelumab
Tezepelumab subcutaneous injection
Placebo
Placebo subcutaneous injection
Research Site, København NV
Research Site, Hvidovre
Research Site, Roskilde
Research Site, Odense C
Research Site, Vejle
Research Site, Aarhus N
Research Site, Aalborg
Research Site, Uijeongbu-si
Research Site, Berlin
Research Site, Marseille
Research Site, Pittsburgh
Research Site, Granada
Research Site, Philadelphia
Research Site, Großhansdorf
Research Site, Incheon
Research Site, Lübeck
Research Site, Abingdon
Research Site, Mooresville
Research Site, Charlotte
Research Site, New Bern
Research Site, Málaga
Research Site, Mt. Pleasant
Research Site, Brest
Research Site, Rock Hill
Research Site, Panama City
Research Site, Orlando
Research Site, Brandon
Research Site, Tampa
Research Site, Montpellier
Research Site, Haifa
Research Site, Dothan
Research Site, Grenoble
Research Site, Daegu
Research Site, Columbus
Research Site, Nantes
Research Site, Alzira
Research Site, Kfar Saba
Research Site, Buckley
Research Site, Jeonju
Research Site, Mainz
Research Site, Rapid City
Research Site, Frankfurt
Research Site, Lyon
Research Site, Edmond
Research Site, McKinney
Research Site, Amiens
Research Site, Beersheba
Research Site, Albuquerque
Research Site, Jerusalem
Research Site, Jerusalem
Research Site, Upland
Research Site, Huntington Beach
Research Site, Newport Beach
Research Site, Westminster
Research Site, Medford
Research Site, Everett
Research Site, Rehovot
Research Site, Ashkelon
Research Site, New Haven
Research Site, Winter Park
Research Site, Calgary
Research Site, Sherwood Park
Research Site, Vancouver
Research Site, Truro
Research Site, Burlington
Research Site, Hamilton
Research Site, Montreal
Research Site, Québec
Research Site, Québec
Research Site, Saint-Charles-Borromée
Research Site, Trois-Rivières
Research Site, Eindhoven
Research Site, Heerlen
Research Site, Rotterdam
Research Site, Rotterdam
Research Site, Zutphen
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Barcelona
Research Site, Mérida (Badajoz)
Research Site, Bradford
Research Site, Chertsey
Research Site, Cottingham
Research Site, Glasgow
Research Site, London
Research Site, Newcastle upon Tyne
Research Site, Wakefield
Lead Sponsor
Collaborators (1)
Amgen
INDUSTRY
AstraZeneca
INDUSTRY